Trelegy Ellipta

Trelegy Ellipta is a prescription inhaler used for the long-term treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains three active ingredients—fluticasone furoate (a corticosteroid), umeclidinium (a long-acting muscarinic antagonist), and vilanterol (a long-acting beta2-adrenergic agonist)—which work together to reduce inflammation, relax airways, and improve breathing.

Benefits:

• Provides 24-hour symptom control with once-daily use.
• Reduces airway inflammation, helping prevent flare-ups.
• Relaxes airway muscles for easier breathing.
• Helps improve lung function in COPD and asthma patients.
• Convenient preloaded inhaler—no need to assemble or shake before use.

Dosage:

• Inhale once daily at the same time each day.
• Do not take more than one inhalation in 24 hours.
• Follow your doctor’s prescribed dosage for COPD or asthma.

Warnings and Precautions:

• Not for sudden breathing problems or asthma attacks—use a rescue inhaler instead.
• May increase the risk of pneumonia in COPD patients.
• Can cause increased heart rate, high blood pressure, or nervousness.
• Inform your doctor if you have glaucoma, osteoporosis, or heart conditions.
• Rinse mouth with water after each use to reduce the risk of oral thrush.

Usage Instructions:

• Open the cover of the inhaler until you hear a click.
• Exhale fully away from the inhaler.
• Place the mouthpiece between your lips and inhale deeply.
• Hold your breath for about 5 seconds, then exhale slowly.
• Close the inhaler and rinse your mouth with water.

Storage Information:

• Store at room temperature (15°C to 30°C).
• Keep in a dry place away from moisture and heat.
• Keep out of reach of children.

Common Side Effects:

• Sore throat or cough.
• Hoarseness or voice changes.
• Headache or dizziness.
• Muscle cramps or joint pain.
• Increased risk of respiratory infections.